Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide-mediated immune responses in specific immunotherapy.

B M Haselden1, A B Kay, M Larché

  • 1Allergy and Clinical Immunology, Imperial College School of Medicine, National Heart and Lung Institute, London, UK.

International Archives of Allergy and Immunology
|September 6, 2000
PubMed
Summary

Peptide immunotherapy offers a safer alternative to traditional allergen extracts for allergic diseases. Shorter peptides, targeting specific T cell epitopes, show promise in reducing allergic reactions and improving treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunosuppression in Chronic Asthma.

International archives of allergy and immunology·2021
Same author

The early history of the eosinophil.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria.

The British journal of dermatology·2014
Same author

Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin.

The British journal of dermatology·2014
Same author

Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients.

International archives of allergy and immunology·2012

Area of Science:

  • Immunology
  • Allergy Research
  • Clinical Therapeutics

Background:

  • Conventional immunotherapy with whole allergen extracts is effective for allergic diseases but carries risks of anaphylaxis.
  • Short peptides targeting T cell epitopes offer a potential alternative by avoiding IgE cross-linking on mast cells and basophils.

Purpose of the Study:

  • To review the concept of peptide immunotherapy.
  • To discuss recent studies on the efficacy and safety of peptide immunotherapy for allergic conditions.

Main Methods:

  • Review of existing clinical studies and preliminary data on peptide immunotherapy.
  • Analysis of peptide characteristics, including length and MHC-binding specificity.
  • Comparison of peptide immunotherapy with conventional immunotherapy approaches.

Related Experiment Videos

Main Results:

  • Initial studies show efficacy of peptide immunotherapy, with some adverse events reported.
  • Shorter peptides (≤20 amino acids) with defined MHC-binding specificity may enhance efficacy.
  • Incremental dosing strategies, similar to conventional immunotherapy, are being explored.

Conclusions:

  • Peptide immunotherapy presents a promising, potentially safer approach to treating allergic diseases.
  • Further research into optimized peptide design and administration is warranted.
  • This therapeutic strategy may reduce the incidence of severe allergic reactions.